Immune Response to Fungal Pathogens
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Fungi rarely cause disease in individuals with normal immunity. However, fungi present in the normal biota of the skin, mucous membranes, intestinal tract, and fungi in the environment that are normally non-pathogenic, can cause life-threatening infections in individuals with suppressed immunity. In the past decades, the prevalence of opportunistic fungal infections has increased, and these are associated with lowered immunity due to chemotherapy, HIV infection, and aging. The development of traditional antifungal agents has not kept pace with the increasing prevalence of invasive fungal infections, and the resistance to antifungal agents has become a major problem. Fortunately, study of the molecular and cellular mechanisms of the host immune response to fungi is increasing day-by-day. These studies indicate that fungal-specific mechanisms exist in the human body, including maintenance of immunological homeostasis in tissues, destruction of homeostasis by fungal infections, elimination of fungi by the host immune response, and recovery of homeostasis. Research into the mechanisms of fungal infection in humans suggests a new treatment paradigm that goes beyond traditional antifungal agents. Vaccines against fungi and immunotherapy using the host immune mechanism against fungi have recently been developed and are nearing use in the clinic.
Abstract
Fungi rarely cause disease in individuals with normal immunity. However, fungi present in the normal biota of the skin, mucous membranes, intestinal tract, and fungi in the environment that are normally non-pathogenic, can cause life-threatening infections in individuals with suppressed immunity. In the past decades, the prevalence of opportunistic fungal infections has increased, and these are associated with lowered immunity due to chemotherapy, HIV infection, and aging. The development of traditional antifungal agents has not kept pace with the increasing prevalence of invasive fungal infections, and the resistance to antifungal agents has become a major problem. Fortunately, study of the molecular and cellular mechanisms of the host immune response to fungi is increasing day-by-day. These studies indicate that fungal-specific mechanisms exist in the human body, including maintenance of immunological homeostasis in tissues, destruction of homeostasis by fungal infections, elimination of fungi by the host immune response, and recovery of homeostasis. Research into the mechanisms of fungal infection in humans suggests a new treatment paradigm that goes beyond traditional antifungal agents. Vaccines against fungi and immunotherapy using the host immune mechanism against fungi have recently been developed and are nearing use in the clinic.
참고문헌 (62)
- Bourgeois C, "Fungal attacks on mammalian hosts : pathogen elimination requires sensing and tasting", Curr Opin Microbiol, 13, pp.401~408 (2010)
- Latge JP, "Tasting the fungal cell wall", Cell Microbiol, 12, pp.863~872 (2010)
- Brown GD, "Innate antifungal immunity : the key role of phagocytes", Annu Rev Immunol, 29, pp.1~21 (2011)
- Geijtenbeek TB, "Signalling through C-type lectin receptors : shaping immune responses", Nat Rev Immunol, 9, pp.465~479 (2009)
- Bi L, "CARD9 mediates dectin-2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans", J Biol Chem, 285, pp.25969~25977 (2010)
- Jia XM, "CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity", J Exp Med, 211, pp.2307~2321 (2014)
- Cambi A, "Dendritic cell interaction with Candida albicans critically depends on N-linked mannan", J Biol Chem, 283, pp.20590~20599 (2008)
- Graham LM, "The C-type lectin receptor CLECSF8(CLEC4D)is expressed by myeloid cells and triggers cellular activation through Syk kinase", J Biol Chem, 287, pp.25964~25974 (2012)
- Zhu LL, "C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection", Immunity, 39, pp.324~334 (2013)
- Wang T, "Dectin-3 deficiency promotes colitis development due to impaired antifungal innate immune responses in the gut", PLoS Pathog, 12, pp.e1005662~ (2016)
- van de Veerdonk FL, "Host-microbe interactions : innate pattern recognition of fungal pathogens", Curr Opin Microbiol, 11, pp.305~312 (2008)
- Carvalho A, "Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation", Exp Hematol, 37, pp.1022~1029 (2009)
- van der Graaf CA, "Toll-like receptor 4Asp299Gly", Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection, 2006, pp.17, 29~34
- Carvalho A, "Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis", J Infect Dis, 197, pp.618~621 (2008)
- Moretti S, "The contribution of PARs to inflammation and immunity to fungi", Mucosal Immunol, 1, pp.156~168 (2008)
- Said-Sadier N, "Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase", PLoS One, 5, pp.e10008~ (2010)
- Gross O, "Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence", Nature, 459, pp.433~436 (2009)
- Rehaume LM, "Lessons from the inflammasome : a molecular sentry linking Candida and Crohn's disease", Trends Immunol, 31, pp.171~175 (2010)
- Bianchi ME, "DAMPs, PAMPs and alarmins: all we need to know about danger", J Leukoc Biol, 81, pp.1~5 (2007)
- Sorci G, "The danger signal S100B integrates pathogen-and danger-sensing pathways to restrain inflammation", PLoS Pathog, 7, pp.e1001315~ (2011)
- Rizzetto L, "A systems biology approach to the mutual interaction between yeast and the immune system", Immunobiology, 215, pp.762~769 (2010)
- Huang H, "Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists", Infect Immun, 77, pp.1774~1781 (2009)
- Bonifazi P, "Intranasally delivered siRNA targeting PI3K", Akt, Mucosal Immunol, pp.2010, 3[DOI]
- Igyarto BZ, "Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses", Immunity, 35, pp.260~272 (2011)
- Kashem SW, "Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation", Immunity, 42, pp.356~366 (2015)
- Kashem SW, "Nociceptive sensory fibers drive interleukin-23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity", Immunity, 43, pp.515~526 (2015)
- Nesbit L, "Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells", Infect Immun, 78, pp.309~315 (2010)
- Romani L, "Immunity to fungal infections", Nat Rev Immunol, 4, pp.1~23 (2004)
- Zhang Y, "Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99", Am J Pathol, 175, pp.2489~2500 (2009)
- Brasch J, "Pathogenesis of tinea", J Dtsch Dermatol Ges, 8, pp.780~786 (2010)
- Kreindler JL, "Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis", J Clin Invest, 120, pp.3242~3254 (2010)
- Kling HM, "Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection", Infect Immun, 78, pp.4320~4330 (2010)
- Subramaniam KS, "The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans", J Immunol, 184, pp.5755~5767 (2010)
- Conti HR, "Oral-resident natural Th17cells and gammadelta T cells control opportunistic Candida albicans infections", J Exp Med, 211, pp.2075~2084 (2014)
- Gladiator A, "Cutting edge : IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection", J Immunol, 190, pp.521~525 (2013)
- De Luca A, "IL-22 defines a novel immune pathway of antifungal resistance", Mucosal Immunol, 3, pp.361~373 (2010)
- Ryan KR, "Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED", Clin Exp Immunol, 154, pp.406~414 (2008)
- Lin L, "Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice", PLoS Pathog, 5, pp.e1000703~ (2009)
- Cheng SC, "Candida albicans dampens host defense by downregulating IL-17 production", J Immunol, 185, pp.2450~2457 (2010)
- Loures FV, "TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection", J Immunol, 183, pp.1279~1290 (2009)
- Ahlgren KM, "Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model", Eur J Immunol, 41, pp.235~245 (2011)
- Romani L, "Protective tolerance to fungi : the role of IL-10 and tryptophan catabolism", Trends Microbiol, 14, pp.183~189 (2006)
- Ferreira MC, "Involvement of regulatory T cells in the immunosuppression characteristic of patients with paracoccidioidomycosis", Infect Immun, 78, pp.4392~4401 (2010)
- Clark RA, "Resident memory T cells in human health and disease", Sci Transl Med, 7, pp.269~ (2015)
- Jiang X, "Skin infection generates non-migratory memory CD8+T(RM)cells providing global skin immunity", Nature, 483, pp.227~231 (2012)
- Park CO, "The emerging role of resident memory T cells in protective immunity and inflammatory disease", Nat Med, 21, pp.688~697 (2015)
- Gebhardt T, "Different patterns of peripheral migration by memory CD4+ and CD8+ T cells", Nature, 477, pp.216~219 (2011)
- Glennie ND, "Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection", J Exp Med, 212, pp.1405~1414 (2015)
- Park CO, "Staged development of long-lived T-cell receptor alphabeta TH17 resident memory T-cell population to Candida albicans after skin infection", J Allergy Clin Immunol, 142, pp.647~662 (2018)
- Wiseman JC, "Perforindependent cryptococcal microbicidal activity in NK cells requires PI3K-dependent ERK1", 2 signaling, 2007, pp.178, 6456~6464
- Whitney PG, "Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection", PLoS Pathog, 10, pp.e1004276~ (2014)
- Li SS, "The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients", Cell Host Microbe, 14, pp.387~397 (2013)
- Vitenshtein A, "NK cell recognition of Candida glabrata through binding of NKp46 and NCR1 to fungal ligands Epa1, Epa6, and Epa7", Cell Host Microbe, 20, pp.527~534 (2016)
- Ziegler S, "CD56 Is a pathogen recognition receptor on human natural killer cells", Sci Rep, 7, pp.6138~ (2017)
- Armstrong-James D, "Immunotherapeutic approaches to treatment of fungal diseases", Lancet Infect Dis, 17, pp.e393~ (2017)
- Perruccio K, "Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation", Blood, 106, pp.4397~4406 (2005)
- Kumaresan PR, "Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection", Proc Natl Acad Sci U S A, 111, pp.10660~10665 (2014)
- Levitz SM, "Exploiting fungal cell wall components in vaccines", Semin Immunopathol, 37, pp.199~207 (2015)
- Torosantucci A, "A novel glyco-conjugate vaccine against fungal pathogens", J Exp Med, 202, pp.597~606 (2005)
- Specht CA, "Protection against experimental Cryptococcosis following vaccination with glucan particles containing Cryptococcus alkaline extracts", mBio, 6, pp.e01905~01915 (2015)
- De Bernardis F, "A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models", Vaccine, 30, pp.4490~4498 (2012)
- Schmidt CS, "NDV-3, a recombinant alum-adjuvanted va-c cine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults", Vaccine, 30, pp.7594~7600 (2012)
